COO
Price
$61.21
Change
-$0.44 (-0.71%)
Updated
Oct 23 closing price
Capitalization
11.64B
41 days until earnings call
Intraday BUY SELL Signals
SOLV
Price
$85.40
Change
-$2.05 (-2.34%)
Updated
Oct 23, 04:59 PM (EDT)
Capitalization
14.89B
13 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

COO vs SOLV

COO vs SOLV Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
COO vs. SOLV commentary
Oct 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COO is a StrongBuy and SOLV is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for COO with price predictions
Oct 22, 2026

COO's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for COO turned positive on September 25, 2026. Looking at past instances where COO's MACD turned positive, the stock continued to rise in 24 of 41 cases over the following month. The odds of a continued upward trend are 59%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 16, 2026. You may want to consider a long position or call options on COO as a result. In 49 of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 54%.

Following a +2.04% 3-day Advance, the price is estimated to grow further. Considering data from situations where COO advanced for three days, in 152 of 271 cases, the price rose further within the following month. The odds of a continued upward trend are 56%.

The Aroon Indicator entered an Uptrend today. In 115 of 222 cases where COO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 52%.

Bearish Trend Analysis

The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where COO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 60%.

COO broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 58 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.398) is normal, around the industry mean (4.961). P/E Ratio (20.891) is within average values for comparable stocks, (37.232). Projected Growth (PEG Ratio) (0.532) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (2.526) is also within normal values, averaging (56.876).

The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating fairly steady price growth. COO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 80 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 84 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. COO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

A.I.Advisor
a Summary for SOLV with price predictions
Oct 22, 2026

SOLV in upward trend: price expected to rise as it breaks its lower Bollinger Band on October 07, 2026

SOLV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 11 of 14 cases where SOLV's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 79%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where SOLV's RSI Oscillator exited the oversold zone, 14 of 19 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 74%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 19 of 30 cases where SOLV's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 63%.

The Momentum Indicator moved above the 0 level on October 21, 2026. You may want to consider a long position or call options on SOLV as a result. In 29 of 45 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 64%.

The Moving Average Convergence Divergence (MACD) for SOLV just turned positive on October 22, 2026. Looking at past instances where SOLV's MACD turned positive, the stock continued to rise in 12 of 24 cases over the following month. The odds of a continued upward trend are 50%.

Following a +1.23% 3-day Advance, the price is estimated to grow further. Considering data from situations where SOLV advanced for three days, in 99 of 149 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.

Bearish Trend Analysis

SOLV moved below its 50-day moving average on October 01, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for SOLV crossed bearishly below the 50-day moving average on October 06, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 5 of 7 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 71%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SOLV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 59%.

The Aroon Indicator for SOLV entered a downward trend on October 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 30 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 43 (best 1 - 100 worst), indicating steady price growth. SOLV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 63 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.102) is normal, around the industry mean (4.961). P/E Ratio (10.626) is within average values for comparable stocks, (37.232). Projected Growth (PEG Ratio) (1.220) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (1.871) is also within normal values, averaging (56.876).

The Tickeron PE Growth Rating for this company is 94 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SOLV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

FUNDAMENTALS RATINGS
COO: Fundamental Ratings
COO
OUTLOOK RATING
1..100
21
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
80
PRICE GROWTH RATING
1..100
59
P/E GROWTH RATING
1..100
84
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
COOSOLV
RSI
ODDS (%)
Bearish Trend 2 days ago
48%
Bullish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
61%
Bullish Trend 2 days ago
63%
Momentum
ODDS (%)
Bullish Trend 2 days ago
54%
Bullish Trend 2 days ago
64%
MACD
ODDS (%)
Bullish Trend 2 days ago
59%
Bullish Trend 2 days ago
50%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
55%
Bearish Trend 2 days ago
58%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
52%
Bearish Trend 2 days ago
64%
Advances
ODDS (%)
Bullish Trend 4 days ago
56%
Bullish Trend 2 days ago
66%
Declines
ODDS (%)
Bearish Trend 16 days ago
60%
Bearish Trend 5 days ago
59%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
66%
Bullish Trend 2 days ago
79%
Aroon
ODDS (%)
Bullish Trend 2 days ago
52%
Bearish Trend 2 days ago
52%
COMPARISON
Comparison
Oct 24, 2026
Stock price -- (COO: $61.65 vs. SOLV: $87.45)
Brand notoriety: COO and SOLV are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: COO: 81% vs. SOLV: 83%
Market capitalization -- COO: $11.72B vs. SOLV: $14.89B
COO [@Pharmaceuticals: Other] is valued at $11.72B. SOLV’s [@Pharmaceuticals: Other] market capitalization is $14.89B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $126 to $156.8B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $9.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COO’s FA Score shows that 0 FA rating(s) are green while SOLV’s FA Score has 1 green FA rating(s).

  • COO’s FA Score: 0 green, 5 red.
  • SOLV’s FA Score: 1 green, 4 red.
According to our system of comparison, SOLV is a better buy in the long-term than COO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COO’s TA Score shows that 4 TA indicator(s) are bullish while SOLV’s TA Score has 6 bullish TA indicator(s).

  • COO’s TA Score: 4 bullish, 4 bearish.
  • SOLV’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, SOLV is a better buy in the short-term than COO.

Price Growth

COO (@Pharmaceuticals: Other) experienced а +7.40% price change this week, while SOLV (@Pharmaceuticals: Other) price change was -0.47% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.86%. For the same industry, the average monthly price growth was -3.31%, and the average quarterly price growth was +7.53%.

Reported Earning Dates

COO is expected to report earnings on Dec 03, 2026.

SOLV is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (+2.86% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

View a ticker or compare two or three
COO
Daily Signal:
Gain/Loss:
SOLV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

COO and

Correlation & Price change

A.I.dvisor indicates that over the last year, COO has been loosely correlated with A. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if COO jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COO
1D Price
Change %
COO100%
+4.54%
A - COO
50%
Loosely correlated
-2.17%
BDX - COO
50%
Loosely correlated
+3.13%
ICUI - COO
46%
Loosely correlated
+4.66%
DHR - COO
46%
Loosely correlated
-1.76%
SYK - COO
44%
Loosely correlated
+3.19%
More

SOLV and

Correlation & Price change

A.I.dvisor indicates that over the last year, SOLV has been loosely correlated with ICUI. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if SOLV jumps, then ICUI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SOLV
1D Price
Change %
SOLV100%
+0.90%
ICUI - SOLV
49%
Loosely correlated
+4.66%
BAX - SOLV
48%
Loosely correlated
+3.85%
ALGN - SOLV
47%
Loosely correlated
+2.74%
COO - SOLV
45%
Loosely correlated
+4.54%
BDX - SOLV
45%
Loosely correlated
+3.13%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
ARKM.X0.1291530.001815
+1.43%
Arkham cryptocurrency
FIS.X0.0014380.000008
+0.59%
StaFi cryptocurrency
TLM.X0.001220-0.000066
-5.17%
Alien Worlds cryptocurrency
AVAX.X9.116143-0.532255
-5.52%
Avalanche cryptocurrency
DYDX.X0.113664-0.006931
-5.75%
dYdX cryptocurrency